Cholecalciferol pharmacology
Pro Research Analysisby 
Searched over 200M research papers for "cholecalciferol pharmacology"
Cholecalciferol Pharmacology: Absorption, Metabolism, and Drug Interactions
Cholecalciferol, also known as vitamin D3, is an essential nutrient involved in calcium and phosphate homeostasis. When administered orally, cholecalciferol is absorbed in the intestine and converted in the liver to calcidiol, its main circulating form. Further conversion in the kidneys produces calcitriol, the active form that exerts biological effects on various tissues .
A study examining the pharmacokinetic interaction between cholecalciferol and bazedoxifene found that co-administration led to a mild reduction in cholecalciferol exposure, as measured by maximum plasma concentration (Cmax) and area under the curve (AUC). However, this interaction was not clinically significant, and the combination was well tolerated, with only mild adverse events reported .
Cholecalciferol in Chronic Kidney Disease and Mineral Metabolism
Cholecalciferol supplementation is particularly important in patients with chronic kidney disease (CKD), where vitamin D deficiency can accelerate secondary hyperparathyroidism (SHPT). High daily doses of cholecalciferol in CKD patients were shown to significantly increase calcidiol levels, stabilize parathyroid hormone (PTH) concentrations, and increase calcitriol without causing hypercalcemia or other side effects. This suggests that cholecalciferol can safely halt the progression of SHPT in CKD stages 3–4 .
Neuropsychiatric and Antidepressant Effects of Cholecalciferol
Research in animal models indicates that cholecalciferol may have antidepressant-like effects. In mice exposed to chronic corticosterone (a model for depression), cholecalciferol administration reduced depressive-like behaviors and reversed hippocampal glucocorticoid receptor impairment. These effects were similar to those seen with fluoxetine, a standard antidepressant. Cholecalciferol also reduced markers of neuroinflammation, such as NLRP3 inflammasome-related proteins, and oxidative stress in the brain, suggesting a role in modulating stress pathways and inflammation 34.
Cholecalciferol and Renal Protection in Acute Kidney Injury
Cholecalciferol has shown protective effects in models of acute kidney injury (AKI) caused by ischemia/reperfusion. In both animal and patient studies, vitamin D deficiency was associated with worse renal outcomes. Cholecalciferol pretreatment reduced kidney cell injury, improved renal function, and decreased the release of proinflammatory cytokines. Mechanistically, it inhibited reactive oxygen species (ROS) production, suppressed the NF-κB signaling pathway, and reduced pyroptosis (a form of programmed cell death), highlighting its potential as a therapeutic agent in AKI .
Conclusion
Cholecalciferol plays a vital role in mineral metabolism, neuroprotection, and renal health. Its pharmacokinetics are generally stable, with only mild interactions when combined with other drugs like bazedoxifene. High-dose supplementation is effective and safe in CKD patients, and emerging evidence supports its benefits in neuropsychiatric disorders and kidney injury through anti-inflammatory and antioxidant mechanisms 1234+1 MORE.
Sources and full results
Most relevant research papers on this topic